PTSD

Enveric Biosciences to Participate in the Microdose Psychedelic Capital Conference on May 26, 2022

Retrieved on: 
Tuesday, May 24, 2022

NAPLES, FLA, May 24, 2022 /PRNewswire/ - Enveric Biosciences , Inc.(NASDAQ:ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that Avani Kanubaddi, President and Chief Operating Officer of Enveric, will participate virtually in Microdose's Psychedelic Capital: May 2022 Conference to be held virtually on May 26, 2022.

Key Points: 
  • NAPLES, FLA, May 24, 2022 /PRNewswire/ - Enveric Biosciences , Inc.(NASDAQ:ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that Avani Kanubaddi, President and Chief Operating Officer of Enveric, will participate virtually in Microdose's Psychedelic Capital: May 2022 Conference to be held virtually on May 26, 2022.
  • Mr. Kanubaddi will participate on a panel "The Spinoffs - Divide and Conquer" on Thursday, May 26th at 4:05 p.m.
  • The panel will discuss the latest spinoffs among publicly traded companies to stay competitive, honor the shareholders and combat the markets.
  • Enveric Biosciences , Inc. (NASDAQ: ENVB) is a neuroscience-focused pharmaceutical company developing next-generation, psychedelic-inspired mental health medicines.

American Addiction Centers Hosts Live Panel on May 25 to Discuss Addiction Among Veterans and Service Members

Retrieved on: 
Tuesday, May 24, 2022

BRENTWOOD, Tenn., May 24, 2022 (GLOBE NEWSWIRE) -- In honor of Military Appreciation Month, American Addiction Centers (AAC) is hosting a live online panel discussion May 25 at 2 p.m. EST with several of its therapists who provide addiction treatment to our nations heroes.

Key Points: 
  • BRENTWOOD, Tenn., May 24, 2022 (GLOBE NEWSWIRE) -- In honor of Military Appreciation Month, American Addiction Centers (AAC) is hosting a live online panel discussion May 25 at 2 p.m. EST with several of its therapists who provide addiction treatment to our nations heroes.
  • The panel will air live on AACs Facebook , LinkedIn and YouTube channels.
  • American Addiction Centers also partners with dozens of VA medical centers nationwide as a community care provider to ensure more veterans have timely access to addiction treatment year-round.
  • American Addiction Centers is a leading provider of inpatient and outpatient substance abuse treatment services.

WIMI Hologram Academy: Psychological application of multi-perceptual interactive experience of virtual reality technology

Retrieved on: 
Monday, May 23, 2022

Scientists from WIMI Hologram Academy of WIMI Hologram Cloud Inc.(NASDAQ: WIMI), discussed the VR technology in the treatment of mental disorders such as post-traumatic stress disorder, anxiety disorder, and phobia.

Key Points: 
  • Scientists from WIMI Hologram Academy of WIMI Hologram Cloud Inc.(NASDAQ: WIMI), discussed the VR technology in the treatment of mental disorders such as post-traumatic stress disorder, anxiety disorder, and phobia.
  • Virtual reality technology was applied to psychology even later, only more than 20 years old.
  • In the context of virtual reality situations or virtual reality worlds, psychologists can better treat psychological anxiety through professional psychological guidance.
  • Traditional psychological behavior training mainly includes extreme psychological behavior training methods, cognitive psychological behavior training methods, situational psychological behavior training methods, and implied psychological behavior training methods.

Silo Pharma Announces Successful Dosing of Patients Suffering from Parkinson’s Disease in Psilocybin Study

Retrieved on: 
Thursday, May 19, 2022

ENGLEWOOD CLIFFS, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announces that it in conjunction with the University of California San Francisco (UCSF), researchers have successfully dosed patients suffering from Parkinsons disease.

Key Points: 
  • ENGLEWOOD CLIFFS, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announces that it in conjunction with the University of California San Francisco (UCSF), researchers have successfully dosed patients suffering from Parkinsons disease.
  • As part of this study, the researchers are collecting blood samples to determine the effects of psilocybin on inflammatory markers of patients who have exhibited signs of Parkinsons.
  • This study is taking place at The Translational Psychedelic Research (TrPR) Program at UCSF.
  • Inc. is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Parkinsons, and other rare neurological disorders.

BioCorRx and 2B3D to Pilot First-of-its-Kind PTSD and Addiction Treatment Solutions for Veterans in Metaverse Setting

Retrieved on: 
Thursday, May 19, 2022

ANAHEIM, CA, May 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that it is collaborating with 2B3D, a virtual, augmented, and mixed reality technology company, to pursue synergistic veteran care in the metaverse. 

Key Points: 
  • Through our collaboration with BioCorRx, their innovative treatment programs for substance abuse and related disorders will allow us to address those high-risk veterans.
  • We are excited to partner with 2B3D, a veteran-owned and operated team that has developed an innovative virtual reality platform for veterans in the metaverse.
  • We look forward to collaborating on the integration of our content into their metaverse to deliver a groundbreaking program with 2B3D shortly.
  • BioCorRx Inc. (OTCQB: BICX) is an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders.

Addex Announces Participation in the H.C. Wainwright Global Investment Conference

Retrieved on: 
Thursday, May 19, 2022

Geneva, Switzerland, May 19, 2022 - Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, will be virtually attending the H.C. Wainwright Global Investment Conference taking place May 23 - 26, 2022.

Key Points: 
  • Geneva, Switzerland, May 19, 2022 - Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, will be virtually attending the H.C. Wainwright Global Investment Conference taking place May 23 - 26, 2022.
  • Mr. Dyer has also submitted a pre-recorded video presentation to the conference, in which he provides a corporate update and discusses recent developments at Addex.
  • Mr. Dyer will be available for virtual one-on-one meetings throughout the conference.
  • Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.

Decorated U.S. Army Veteran Surprised with a New Mortgage-Free Centex Home in Arizona Through PulteGroup’s Built to Honor® Program

Retrieved on: 
Thursday, May 19, 2022

In an emotional surprise reveal event, United States Army Sergeant William McCoy learned that he will be the recipient of a brand-new mortgage-free Centex home, awarded through PulteGroups Built to Honor program.

Key Points: 
  • In an emotional surprise reveal event, United States Army Sergeant William McCoy learned that he will be the recipient of a brand-new mortgage-free Centex home, awarded through PulteGroups Built to Honor program.
  • There is no better way to demonstrate our support and appreciation for our nations heroes than by doing what we do best: building homes.
  • Built specifically for the McCoy family, the new construction single-family home will be 1,915 square feet, with four bedrooms and two bathrooms.
  • This will be the third home dedicated in Arizona through the Built to Honor program.

Virpax Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference

Retrieved on: 
Thursday, May 19, 2022

Event: Virpax Pharma Virtual Presentation at the H.C. Wainwright Global Investment Conference

Key Points: 
  • Event: Virpax Pharma Virtual Presentation at the H.C. Wainwright Global Investment Conference
    Time: On Demand starting at 7:00 a.m.
  • ET
    For more information on the H.C. Wainwright Global Investment Conference or to schedule a one-on-one meeting with Virpax management, please contact your conference representative or you may also email your request to [email protected] or call (212) 661-2231.
  • Virpax is developing branded, non-addictive pain management products candidates using its proprietary technologies to optimize and target drug delivery.
  • H.C. Wainwright is a fullservice investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions.

FOUNDATION OF HOPE GIVES OVER $478,000 TO MENTAL ILLNESS RESEARCH

Retrieved on: 
Tuesday, May 24, 2022

RALEIGH, N.C., May 24, 2022 /PRNewswire/ -- Continuing its ongoing efforts to curb the debilitating effects of mental illness, the Foundation of Hope for Research and Treatment of Mental Illness (FOH) will award over $478,000 in research grants to nine investigators in the Department of Psychiatry at The University of North Carolina at Chapel Hill.

Key Points: 
  • RALEIGH, N.C., May 24, 2022 /PRNewswire/ -- Continuing its ongoing efforts to curb the debilitating effects of mental illness, the Foundation of Hope for Research and Treatment of Mental Illness (FOH) will award over $478,000 in research grants to nine investigators in the Department of Psychiatry at The University of North Carolina at Chapel Hill.
  • "Since the pandemic, it has become crystal clear that more people than ever are suffering with mental illness," says Shelley Belk, Executive Director of the FOH.
  • "So, we are determined to continue funding critical mental illness research projects that have the potential to change the trajectory of people's lives.
  • The Foundation of Hope for Research and Treatment of Mental Illness is a 501(c)(3) nonprofit organization based in Raleigh, North Carolina.

Unlike in Hollywood Blockbusters, the TOPGUN Pilots in 'No Fallen Heroes' are Real... and their Enemy is Veteran Suicide

Retrieved on: 
Tuesday, May 24, 2022

BOCA RATON, Fla., May 24, 2022 /PRNewswire/ -- Executive Producer Matthew 'Whiz' Buckley and Producer/Director Leigh Simons just dropped a double-barreled announcement regarding their feature-length documentary 'No Fallen Heroes.' First, there will be a VIP by-invitation-only first-look screening of portions of the film on May 28 in Boca Raton, FL. Second, the initial public update on their upcoming spin-off TV series 'No Fallen Heroes: Extraction,' will also be presented. The series will launch in 2023.

Key Points: 
  • First, there will be a VIP by-invitation-only first-look screening of portions of the film on May 28 in Boca Raton, FL.
  • Second, the initial public update on their upcoming spin-off TV series 'No Fallen Heroes: Extraction,' will also be presented.
  • The film is called 'No Fallen Heroes' because everyone who battles mental illness, depression, addiction, trauma, or PTSD is a hero.
  • The 'No Fallen Heroes' presentation will take place on May 28 in Boca Raton, FL, to an elite group of financiers and qualified investors.